H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating and $95.00 price target on Corcept Therapeutics (NASDAQ: CORT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments